Mezzion Pharma Co.Ltd (140410) — Capital Reinvestment Ratio
Mezzion Pharma Co.Ltd (140410) has a Capital Reinvestment Ratio of 1.15x as of September 2023, meaning it reinvests 1% of its operating cash flow (₩4.73 Billion) in capital expenditures (₩5.46 Billion). See Mezzion Pharma Co.Ltd net asset quality index to measure how much of total assets are equity-financed.
Capital Reinvestment Ratio
Operating Cash Flow
Capital Expenditures
Data as of
Mezzion Pharma Co.Ltd Capital Reinvestment Ratio (2012–2015)
This chart tracks Mezzion Pharma Co.Ltd's Capital Reinvestment Ratio across 2 annual periods. Check Mezzion Pharma Co.Ltd cash flow reinvestment rate to assess the company's total reinvestment commitment from operating cash flow.
Annual Capital Reinvestment Ratio for Mezzion Pharma Co.Ltd (2012–2015)
Year-by-year Capital Reinvestment Ratio for Mezzion Pharma Co.Ltd from 2012 to 2015. For live market cap and broader valuation context, see Mezzion Pharma Co.Ltd stock valuation.
| Year | Reinvestment Ratio | Operating CF (KRW) | Capital Expenditures | YoY Change |
|---|---|---|---|---|
| 2015 | 0.32x | ₩1.77 Billion | ₩564.10 Million | ▲ +77.0% |
| 2012 | 0.18x | ₩3.14 Billion | ₩564.10 Million | — |